当前位置: X-MOL 学术Am. J. Kidney Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study
American Journal of Kidney Diseases ( IF 9.4 ) Pub Date : 2024-11-07 , DOI: 10.1053/j.ajkd.2024.08.012
Emilie J. Lambourg PhD, Edouard L. Fu PhD, Stuart McGurnaghan PhD, Bryan R. Conway PhD, Neeraj Dhaun PhD, Christopher H. Grant MPH, Ewan R. Pearson PhD, Patrick B. Mark PhD, John Petrie PhD, Helen Colhoun PhD, Samira Bell MD, Scottish Diabetes Research Network Epidemiology Group, Rory McCrimmon, Catherine Armstrong, Alistair Emslie-Smith, Robert Lindsay, Sandra MacRury, John McKnight, Donald Pearson, Brian McKinstry

Current guidance recommends against the use of metformin in people with advanced kidney impairment despite a lack of supporting evidence. The aim of this observational study was to compare outcomes of patients with type 2 diabetes who continued versus stopped metformin after developing stage 4 chronic kidney disease (CKD) (eGFR <30 ml/min/1.73m2).

中文翻译:


晚期 CKD 患者停止与继续使用二甲双胍:一项全国性的苏格兰目标试验模拟研究



尽管缺乏支持证据,但目前的指南建议不要对晚期肾功能损害患者使用二甲双胍。这项观察性研究的目的是比较 2 型糖尿病患者在发展为 4 期慢性肾脏病 (CKD) 后继续使用与停用二甲双胍的结果 (eGFR <30 ml/min/1.73m2)。
更新日期:2024-11-07
down
wechat
bug